Synthesis and Biological Evaluation of Novel Anthranilamide Derivatives as Anticancer Agents

News   Oct 23, 2013

 
Synthesis and Biological Evaluation of Novel Anthranilamide Derivatives  as Anticancer Agents
 
 
 

RELATED ARTICLES

PhoreMost and Plexxikon Collaborate to Identify Novel Drug Targets

News

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.

READ MORE

Construction of State-of-the-Art Flow Chemistry Facility Commences

News

Construction has commenced on a new $8 million Centre for Industrial Flow Chemistry at the CSIRO’s Normanby Rd Clayton site. The purpose-built, 410m2 state-of-the-art facility will provide local manufacturers access to CSIRO’s flow chemistry technology.

READ MORE

Yuriy Roman: A Chemical Engineer Pursuing Renewable Energy

News

MIT professor, Yuriy Roman, devises new ways to generate useful chemicals and fuels from renewable resources.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE